A STUDY OF THE EFFECT OF ORAL INGESTION OF SILVER FOIL ON LIPID FRACTIONS IN CHICKENS

MILI JAIN

doi:10.22159/ijcpr.2025v17i5.7049

Authors

MILI JAIN Department of Biochemistry, JIET Medical College and Hospital, Jodhpur, Rajasthan, India https://orcid.org/0009-0005-8171-5263

DOI:

https://doi.org/10.22159/ijcpr.2025v17i5.7049

Keywords:

Silver Foil, Lipids, Phospholipids, Triglycerides, Total Cholesterol, HDL-Cholesterol, VLDL-Cholesterol, LDL-Cholesterol, HDL- Cholesterol To Total Cholesterol Ratio, Atherosclerosis, Cardiovascular Health

Abstract

Objective: Silver foil is widely used in Ayurvedic and Unani medicine for various therapeutic purposes, including cardiovascular health. Previous reports have suggested a hypolipidemic effect of silver. This study aimed to evaluate the impact of orally administered silver foil on lipid metabolism in young male chicks.

Methods: A total of 50 male chicks (approximately 1 kg body weight) were divided equally into control and experimental groups. The experimental group received 15 mg of silver foil mixed with ~1 g of mawa sweet once daily for 10 days. Controls were untreated. After the treatment period, all chicks were sacrificed, and blood samples were collected in heparinized vials. Plasma was separated and analysed for lipid fractions, including total lipids, phospholipids, triglycerides, total cholesterol, HDL-cholesterol, VLDL-cholesterol, and LDL-cholesterol. HDL-cholesterol to total cholesterol ratio was also calculated. Statistical analysis was performed using Student’s paired t-test.

Results: Silver analysis revealed 99.5% purity in the foil. Silver levels in the blood and plasma of treated chicks were significantly higher, indicating systemic absorption (4.7 times in blood, 4.4 times in plasma). The experimental group showed significant reductions in total lipids, phospholipids, triglycerides, total cholesterol, LDL-cholesterol, and VLDL-cholesterol, alongside a significant increase in HDL-cholesterol and HDL-C/TC ratio. No signs of toxicity were observed, and body weight increased during the study.

Conclusion: These findings suggest that oral ingestion of silver foil exerts a hypolipidemic effect, notably increasing HDL-cholesterol and reducing atherogenic lipid fractions. Silver foil may hold potential as a natural therapeutic agent for preventing or mitigating atherosclerosis.

Downloads

Download data is not yet available.

References

1. Foldbjerg R, Dang DA, Autrup H, Kjems J, Ornsbo L. Cytotoxicity of silver nanoparticles in human lung cells. J Nanopart Res. 2009;11(7):1645-58.

2. Prabhu S, Poulose EK. The effect of nanosilver on oxidative stress in rat liver and kidney. Int J Nanomedicine. 2012;7:3903-10.

3. Shah S, Sharma M, Pathak N, Garg BS. Impact of silver nanoparticles on lipid metabolism in rats. J Toxicol Environ Health A. 2013;76(6):335-45.

4. Chen X, Schluesener HJ. Nanosilver: a review of nanosilver safety and toxicity. Arch Toxicol. 2011;85(11):1269-81.

5. Sharma M, Singh J, Sharma R, Singh SP. Oxidative stress and genotoxicity induced by silver nanoparticles in human peripheral blood mononuclear cells. Environ Toxicol Pharmacol. 2009;28(2):223-8.

6. Nadkarni AK. Indian materia medica. 3rd ed. Vol. 2. Bombay: Popular Press Prakashan; 1986. p. 14-5.

7. Khanna AT, Sivaraman R, Vohora SB. Analgesic activity of silver preparations used in Indian systems of medicine. Indian J Pharmacol. 1997;29:393-8.

8. Hill CH, Starcher B, Matrone G. Mercury and silver interrelationships with copper. J Nutr. 1964;83:107-10. doi: 10.1093/jn/83.2.107, PMID 14167698.

9. Choudhary P. Effect of ingestion of copper bhasma on circulating lipids and cardiac enzymes. Jaipur: University of Rajasthan; 2001. p. 80.

10. Kayahan S. Cholesterol binding capacity of normal and atherosclerotic intimas. Lancet. 1959;1(7066):223-4. doi: 10.1016/s0140-6736(59)90051-0, PMID 13631974.

11. Sharma DC, Jha J, Sharma P, Gaur BL. Evaluation of safety and efficacy of a gold-containing ayurvedic drug. Indian J Exp Biol. 2001;39(9):892-6. PMID 11831371.

12. Besser GM, Thorner MO. Clinical endocrinology. 2nd ed. London: M Wolfe; 1994. p. 6.2-6.18.

13. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis. 1984;4(4):323-40. doi: 10.1161/01.atv.4.4.323, PMID 6466191.

14. Clarkson TB, Bond MG, Bullock BC. A study on atherosclerosis regression in Macaca mulatta. V. changes in abdominal aorta and carotid and coronary arteries from animals with atherosclerosis induced for 38 m and then regressed for 24 or 48 m at plasma cholesterol concentrations of 300 or 200 mg/dl. Exp Mol Pathol. 1984;41(1):41-96. doi: 10.1016/0014-4800(84)90011-x.

15. Konjufca VH, Pesti GM, Bakalli RI. Modulation of cholesterol levels in broiler meat by dietary garlic and copper. Poult Sci. 1997;76(9):1264-71. doi: 10.1093/ps/76.9.1264, PMID 9276889.

16. Sharma DC. Textbook of biochemistry. Hyderabad: Paras Medical Publisher; 1999. p. 223.

17. Ramakrishnan S, Swami R. Textbook of clinical (medical) biochemistry and immunology; 1995. p. 67-76.